PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2015

Acute Treatment of Resveratrol Alleviates Doxorubicin-Induced Myotoxicity in Aged Skeletal Muscle Through SIRT1-Dependent Mechanisms.

Mouse / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 26450947 ↗2015Reported benefit

Acute Treatment of Resveratrol Alleviates Doxorubicin-Induced Myotoxicity in Aged Skeletal Muscle Through SIRT1-Dependent Mechanisms.

MouseChemical/toxinSenescence-accelerated mouse prone 8 (SAMP8)Male

Model: Doxorubicin-induced skeletal muscle myotoxicity in young and aged senescence-accelerated mice

Resveratrol attenuated doxorubicin-induced increases in apoptotic and catabolic markers in aged skeletal muscle, and these benefits were abolished by the SIRT1 inhibitors sirtinol or EX527. Insulin signalling markers were unaffected by either doxorubicin or resveratrol.

Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.